This Next-Gen Obesity Drug: Can It Save Novo Nordisk?
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Find out which option tends to yield steadier income—index funds or bonds—and how to blend them for reliability and growth.
24,934 articlesNovo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
Newrez is rolling out TitlePass in its wholesale channel, allowing brokers to waive the lender title insurance on cer...
BYD could shift from a large EV maker to a vertically integrated electrification leader. This piece lays out the thre...
An insider stake moved when a Freshworks executive sold over 32,577 shares for roughly $275,000. This article breaks ...
Barclays lifts ratings on Arthur J. Gallagher and Willis Towers Watson, contending that disruption fears overdone, sa...
Jim Cramer spotlights a surprising quarter from Marvell, arguing the company’s data center-focused growth could redef...
Rising tensions around the Strait Hormuz threaten global oil flows and U.S. energy budgets. Markets are reacting, and...
When markets stumble, strong AI leaders can offer both stability and growth. This guide highlights five AI-driven sto...
Opendoor Technologies shares jumped about 6% as the company posted a strong Q4 and policy tailwinds boosted the stock...
A single viral moment can grab attention, but your hardest-hitting finance lessons come from everyday decisions. Lear...
The Montana Supreme Court delivered a unanimous ruling this week, preserving the 2023 housing reform package aimed at...
Small modular reactors could redefine electricity costs and energy security. This guide breaks down the investment th...